ClinicalTrials.Veeva

Menu

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

TransMedics logo

TransMedics

Status

Completed

Conditions

Liver Transplant

Treatments

Device: OCS Liver

Study type

Observational

Funder types

Industry

Identifiers

NCT05096754
OCS-LVR-02-PAS

Details and patient eligibility

About

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.

Enrollment

74 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Subjects transplanted in the OCS Liver PROTECT CAP

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems